495 related articles for article (PubMed ID: 19218638)
1. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
[TBL] [Abstract][Full Text] [Related]
2. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
[TBL] [Abstract][Full Text] [Related]
3. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
4. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
5. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
Xu XM; Sun TY; Lin JB; Zhang HS
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
[TBL] [Abstract][Full Text] [Related]
6. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
7. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
8. [The influence of smoking on the metalloproteinase 1 (MMP-1) concentration in serum in the group of patients with chronic obstructive pulmonary disease].
Rozyńska R; Jahnz-Rózyk K; Targowski T; Grabowska P; From S
Przegl Lek; 2005; 62(10):1047-50. PubMed ID: 16521950
[TBL] [Abstract][Full Text] [Related]
9. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Bolton CE; Stone MD; Edwards PH; Duckers JM; Evans WD; Shale DJ
Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
[TBL] [Abstract][Full Text] [Related]
10. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
[TBL] [Abstract][Full Text] [Related]
11. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
12. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
[TBL] [Abstract][Full Text] [Related]
15. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
Higashimoto Y; Yamagata Y; Iwata T; Okada M; Ishiguchi T; Sato H; Masuda M; Itoh H
Eur Respir J; 2005 May; 25(5):885-90. PubMed ID: 15863647
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease].
Chen Y; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):324-7. PubMed ID: 15949313
[TBL] [Abstract][Full Text] [Related]
17. Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease.
Ziora D; Dworniczak S; Kozielski J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():809-17. PubMed ID: 19218708
[TBL] [Abstract][Full Text] [Related]
18. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
Calikoğlu M; Unlü A; Tamer L; Ozgür E
Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566
[TBL] [Abstract][Full Text] [Related]
19. Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD.
Chen Y; Chen P; Hanaoka M; Droma Y; Kubo K
Respirology; 2008 Nov; 13(7):1014-21. PubMed ID: 18699805
[TBL] [Abstract][Full Text] [Related]
20. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
Wu SJ; Chen P; Jiang XN; Liu ZJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
